COMPANY

Cognixion

Profile checked Oct 10, 2026

Keywords: ALS (Amyotrophic Lateral Sclerosis) TBI Traumatic Brain Injury SCI - Spinal Cord Injury Stroke Cognixion + Apple Vision Pro Cognixion ONE

Funding and NIH signals

SEC Form D raise Raised $4.05M in debt securities (Form D filed Feb 3, 2026). SEC Form D 0001749036-26-000001 (Feb 3, 2026)
Evidence (1 event)
- Feb 3, 2026 · SEC Form D 0001749036-26-000001
  Name of Issuer: Cognixion Corp; CIK: 1749036; Address: Santa Barbara, CA; Submission type: D; Filing date: 2026-02-03; Industry Group: Other; Date of First Sale: 2026-01-30; Types of Securities Offered: Debt; Business combination transaction: false; Total Offering Amount: 4050000; Total Amount Sold: 4050000; Federal exemptions: 06b
NIH award NIH awarded $1.26M (SBIR Phase II 1R44DC023888-01A1, new, notice Jul 22, 2026). NIH RePORTER 1R44DC023888-01A1 (Jul 22, 2026)
Evidence (1 event)
- Jul 22, 2026 · NIH RePORTER 1R44DC023888-01A1
  Organization: COGNIXION CORPORATION; City/State: SANTA BARBARA, CA; Project number: 1R44DC023888-01A1; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-07-22; FY total cost (award amount): 1258551; Administering IC: National Institute on Deafness and Other Communication Disorders; Project title: BCI and Hybrid BCI Wearable Agency Device for ALS.; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals

Oct 16, 2025 Trial start Not phased (device or behavioral study): Augmented Reality BCI Longitudinal Study for Persons With ALS, Stroke, TBI and SCI Utilizing Cognixion + Apple Vision Pro source ↗
Jan 20, 2025 Trial start Not phased (device or behavioral study): Augmented Reality BCI Longitudinal Study for Persons With Late Stage ALS source ↗

Record	Title	Phase	Status	Start	Primary completion
NCT07209943	Augmented Reality BCI Longitudinal Study for Persons With ALS, Stroke, TBI and SCI Utilizing Cognixion + Apple Vision Pro	Not phased (device or behavioral study)	Not yet recruiting	Oct 16, 2025	Apr 30, 2026 (estimated)
NCT06810219	Augmented Reality BCI Longitudinal Study for Persons With Late Stage ALS	Not phased (device or behavioral study)	Recruiting	Jan 20, 2025	Aug 30, 2025 (estimated)

Annual award amounts. Total $1.3M.

Jul 22, 2026 NIH award 1R44DC023888-01A1 FY2026: $1,258,551 awarded for that fiscal year; activity R44 (SBIR); PI ULLRICH, CHRIS; recipient as written: COGNIXION CORPORATION, SANTA BARBARA, CA. BCI and Hybrid BCI Wearable Agency source ↗